Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB‐1, and androgen receptor

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|73|12|1336-1344

ISSN： 0270-4137

Source： THE PROSTATE, Vol.73, Iss.12, 2013-09, pp. : 1336-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 88, Iss. 1, 2011-12 ,pp. : 25-33

Karger

Access to resources Recommend Favorite

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2535-2545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adipocytes affect castration‐resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD‐L1/NKG2D ligand levels in tumor cells

By  

THE PROSTATE, Vol. 78, Iss. 5, 2018-04 ,pp. : 353-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

YB-1 Protein and Multidrug Resistance of Tumor Cells

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite

Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1291-1305

John Wiley & Sons Inc

Access to resources Recommend Favorite